NCT05319678

Brief Summary

Aims: To evaluate the perception and enjoyment of music in cochlear implant (CI) users using specific questionnaires, and comparing their results with a control group of subjects with normal hearing (NH). To analyze the musical abilities of implantees using the musical tool Meludia, and compare the results with the control group. To perfom a voice analysis in implanted patients, compare it with their NH peers, and check if an association with musical perception is observed. Design: Cross-sectional study, both the CI recipients and NH control subjects were assessed once. Setting and subjects: Pre-or perilingual patients aged 6 to 17 years old, and postlingual adults who underwent cochlear implantation from 2000 to January 2023 at La Paz University Hospital. Control group is set up with their NH peers. Study Variables: Socio-demographic and clinical (current age, age at implantation, sex, educational level) variables will be collected, as well as hearing loss (aetiology, duration of deafness), and surgical (type of implant, complete or partial insertion of the electrodes, date of surgery) data. Data from CI fitting (number of active electrodes, type of audio processor) and hearing outcomes with the CI will also be reviewed. Outcome variables: Specific musical skills questionnaires for adults: Munich Music Questionnaire (MuMu) and Music Related Quality of Life Questionnaire (MuRQoL), which will be validated. Musical questionnaire developed specifically for subjects between 6-17 years old. Musical tool (Meludia) to assess musical perception. Praat software for voice analysis. Analysis of the impact of the different audiological, sociodemographic and clinical variables on hearing outcomes, and on musical perception after cochlear implantation, and comparison with the NH control group.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 10, 2022

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

March 23, 2022

Completed
16 days until next milestone

First Posted

Study publicly available on registry

April 8, 2022

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

August 12, 2025

Status Verified

February 1, 2025

Enrollment Period

3.9 years

First QC Date

March 23, 2022

Last Update Submit

August 6, 2025

Conditions

Outcome Measures

Primary Outcomes (6)

  • Scoring on a specific musical questionnaire for adults: MuMu

    Change in the musical experience and degree of enjoyment of music before and after CI in adult (≥18 years) post-lingual patients with the Munich Music Questionnaire (MuMu).

    3 years

  • Scoring on a specific musical questionnaire for adults: MuRQoL

    Change in music perception with the Music Related Quality of Life (MuRQoL) questionnaire in postlingually hearing adults (≥18 years) with CI and compare it with the results in subjects with normal hearing.

    3 years

  • Translation and validation the MuRQoL questionnaire in Spanish.

    Translation of the MuRQoL questionnaire: Initially, the questionnaire will be translated from English to Spanish by a suitably qualified person. This will be followed by translation from Spanish to English (back-translation) by another qualified person from outside the clinical study. This will ensure that the Spanish version faithfully reproduces the original English version.

    3 years

  • Score on a questionnaire created specifically for individuals aged between 6-17 years that encompasses aspects of musical interests, musical profile, role of music and music-related activities.

    The newly created questionnaire will be in an easily understandable language. The responses of implanted patients will be compared with those of their normal hearing peers.

    3 years

  • Score obtained in the "discovery" level with the Meludia music tool

    To analyse the musical abilities of implanted patients over 6 years of age using the musical tool "Meludia" with its 5 musical categories: rhythm, melody, density, stability and spatialisation, and to compare their results with those obtained in subjects with normal hearing.

    3 years

  • Change in voice quality of CI users compared with their normal hearing control peers.

    Voice analysis: In implanted patients over 6 years, study various parameters to evaluate voice quality, e.g. vocal incapacity index, maximum phonation time, fundamental voice frequency, pitch... and compare them with the results in their normal hearing control peers. Parameters to assess voice quality: Spoken voice: Vocal inability index, Maximum phonation time, Fundamental voice frequency, Jitter, Shimmer, Harmonics to noise ratio (HNR), Smoothed cepstral peak (CPPS) and Spectrogram according to Yanagihara's classification. Sung voice: Pitch (relative to the note emitted by a keyboard), CPPS and Singing power ratio (SPR).

    3 years

Secondary Outcomes (1)

  • The impact of hearing with CI on the perception and enjoyment of music.

    3 years

Study Arms (2)

Cochlear implant users

Pre-or perilingual patients aged 6 to 17 years old, and postlingual adults who underwent cochlear implantation from 2000 to January 2023 at La Paz University Hospital

Other: evaluation with Meludia music software

Normal hearing subjects

Control group is set up with the normal hearing peers of cochlear implant users

Other: evaluation with Meludia music software

Interventions

Measurement instruments: 1. \- MuMu Questionnaire 2. MuRQoL Questionnaire 3. Questionnaire for subjects aged 6-17 years 4. Music tool Meludia (www.meludia.com) 5. Acoustic analysis of the voice: the Praat programme 6. Audiological tests

Also known as: voice analysis with Praat software
Cochlear implant usersNormal hearing subjects

Eligibility Criteria

Age6 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adult patients (≥18 years) with postlingual hearing loss and children (between 6 and 17 years) with prelingual or perilingual hearing loss who have received a CI before the age of 3 years. Patients who have received a CI from 2000 to January 2023 will be included as potential candidates for participation

You may qualify if:

  • Minimum age of 6 years.
  • Patients aged 6-17 years must have been implanted before the age of 3 years (to ensure adequate CI performance).
  • Minimum 12 months experience with the device
  • Indications: unilateral (one CI), bilateral (two CIs), bimodal (one CI in one ear and a hearing aid in the other)
  • At least 80% of electrodes active at the time of assessment.
  • Fluency in Spanish
  • Signed and dated informed consent prior to starting any study procedure.

You may not qualify if:

  • Prelingual or perilingual adults.
  • Disability in addition to hearing impairment (e.g., mental disability).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Universitario de La Paz

Madrid, Madrid, 28046, Spain

RECRUITING

Related Publications (1)

  • Lassaletta L, Calvino M, Sanchez-Cuadrado I, Munoz E, Gavilan J. Can anatomy-based fitting improve musical perception in adult cochlear implant users? Braz J Otorhinolaryngol. 2025 Mar-Apr;91(2):101533. doi: 10.1016/j.bjorl.2024.101533. Epub 2024 Nov 19.

Study Officials

  • Luis Lassaletta

    Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Miryam Calvino

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Target Duration
12 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigador. PhD

Study Record Dates

First Submitted

March 23, 2022

First Posted

April 8, 2022

Study Start

February 10, 2022

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

August 12, 2025

Record last verified: 2025-02

Locations